Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Leukemia 1Congenital Abnormalities 1

Interventions

fludarabine phosphate 73Peripheral Blood Stem Cell Transplantation 63Cyclophosphamide 59Busulfan 51Tacrolimus 46Mycophenolic Acid 46Cytarabine 44Whole-Body Irradiation 41Cyclosporine 37Methotrexate 34Antilymphocyte Serum 33Filgrastim 30Etoposide 29Radiotherapy 22Melphalan 21Flow Cytometry 21Cord Blood Stem Cell Transplantation 17Mitoxantrone 14Methylprednisolone 14Transplantation 13Granulocyte Colony-Stimulating Factor 12Idarubicin 11Clofarabine 11sargramostim 10aldesleukin 10Thiotepa 9Polymerase Chain Reaction 9Alemtuzumab 9merphos 8Therapeutics 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Congenital Abnormalities × Proto-Oncogene Proteins c-kit × Clear all
NCT00509093 2020-03-17

Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy

Case Comprehensive Cancer Center

Phase 2 Completed
32 enrolled 14 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡